Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.48 by 10.42 percent. This is a 1.92 percent increase over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $3.982 billion which beat the analyst consensus estimate of $3.810 billion by 4.53 percent. This is a 2.34 percent increase over sales of $3.891 billion the same period last year.